生技
生物科技板塊聚焦以生命科學為基礎的研發與商業化，涵蓋藥物研發、基因與細胞治療、診斷試劑、合成生物與精準醫療等核心賽道。該板塊總市值為 918.48 billion HKD，24h 漲跌幅 -0.20%，14 檔中，6 檔上漲 (42.86%)，8 檔下跌 (57.14%)。領漲個股為 金斯瑞生物科技 (01548)，24h 漲幅為 +4.47%。在溫和盤整中，由領頭股帶動的韌性顯示這是暫停，而非趨勢反轉。以即將到來的催化事件為動能交易的重點；在回調時逢低布局現金充裕的創新型公司，優先考量已驗證的研發管線與風險控管，而非投機性標的。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 藥明生物02269 | HK$38.66$159.37 | -1.12%-$1.81 | HK$38.66 -1.12% | $158.63$163.49 | ||
 藥明康德02359 | HK$157.0$647.2 | -0.25%-$1.6 | HK$157.0 -0.25% | $644.7$658.7 | ||
 百濟神州06160 | HK$199.7$823.2 | +0.25%+$2.0 | HK$199.7 +0.25% | $815.4$826.1 | ||
 金斯瑞生物科技01548 | HK$16.82$69.34 | +4.47%+$2.96 | HK$16.82 +4.47% | $66.24$69.34 | ||
 康方生物09926 | HK$98.60$406.47 | -0.90%-$3.71 | HK$98.60 -0.90% | $401.32$411.01 | ||
 科倫博泰生物－Ｂ06990 | HK$513.5$2,116.8 | -0.09%-$2.0 | HK$513.5 -0.09% | $2,090.1$2,143.6 | ||
 榮昌生物09995 | HK$85.65$353.09 | +2.94%+$10.10 | HK$85.65 +2.94% | $342.99$355.56 | ||
 康諾亞－Ｂ02162 | HK$82.30$339.28 | -0.60%-$2.06 | HK$82.30 -0.60% | $335.36$343.40 | ||
 藥明合聯02268 | HK$54.35$224.05 | -2.16%-$4.94 | HK$54.35 -2.16% | $222.20$232.09 | ||
 ZAI LAB09688 | HK$14.87$61.30 | -3.31%-$2.10 | HK$14.87 -3.31% | $60.64$63.60 | ||
 泰格醫藥03347 | HK$37.84$155.99 | +1.72%+$2.63 | HK$37.84 +1.72% | $152.36$157.89 | ||
 諾誠健華09969 | HK$13.91$57.34 | +0.79%+$0.45 | HK$13.91 +0.79% | $56.64$57.96 | ||
 復宏漢霖02696 | HK$56.00$230.85 | -0.17%-$0.41 | HK$56.00 -0.17% | $228.38$233.12 | ||
 君實生物－Ｂ01877 | HK$18.90$77.91 | +2.77%+$2.10 | HK$18.90 +2.77% | $75.81$78.03 |